Adjuvant and post-surgical treatment in non-epithelial ovarian cancer

被引：8
作者：
El Helali, Aya [1 ]
Kwok, Gladys Shuk Tak [2 ]
Tse, Ka Yu [2 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Dept Clin Oncol, Li Ka Shing Fac Med, 1-F Professorial Block,102 Pokfulam Rd, Hong Kong, Peoples R China
[2] Univ Hong Kong, Li Ka Shing Fac Med, Queen Mary Hosp, Div Gynaecol Oncol,Dept Obstet & Gynaecol, 6-F Professorial Block,102 Pokfulam Rd, Hong Kong, Peoples R China
来源：
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY | 2022年 / 78卷
关键词：
Non-epithelial ovarian cancer; Ovarian germ cell tumor; Active surveillance; Ovarian sex cord-stromal tumors; Fertility-sparing surgery; GRANULOSA-CELL TUMORS; MALIGNANT GERM-CELL; CORD-STROMAL TUMORS; STAGE-I; AROMATASE INHIBITORS; HORMONE-THERAPY; SURVIVAL; CHEMOTHERAPY; BLEOMYCIN; ETOPOSIDE;
D O I：
10.1016/j.bpobgyn.2021.06.001
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Non-epithelial cancers arising from the ovary are uncommon malignancies. Germ cell tumors of the ovary arise from primordial germ cells, and sex cord-stromal tumors of the ovary represent a cluster of tumors arising from the sex cord and stromal compartment. Most patients diagnosed with germ cell tumors are young adults and adolescent females. In contrast, ovarian sex cordstromal tumors more commonly occur in a mature age group. Advances in the adjuvant management of non-epithelial ovarian cancer following optimal surgical and pathological staging have improved patient survival outcomes. In addition, active surveillance is preferentially assigned to patients diagnosed with stage I germ cell tumor, stage 1A grade 1 immature teratoma, stage 1A yolk sac tumor, and stage 1AI sex cord-stromal tumors. This article discusses the importance of selecting the adjuvant treatment approach most suitable to the patients' surgical and pathological stages, thereby safeguarding patient outcomes. (c) 2022 Elsevier Ltd. All rights reserved.
引用
收藏
页码：74 / 85
页数：12
相关论文
共 86 条
[11]   Surveillance in stage I MOGCTs (malignant ovarian germ cell tumors): A MITO prospective study (multicenter Italian trials in ovarian cancer). [J].
Bergamini, Alice ;
Giorda, Giorgio ;
Ferrandina, Gabriella ;
Cormio, Gennaro ;
Lorusso, Domenica ;
Cassani, Chiara ;
Raspagliesi, Francesco ;
Marinaccio, Marco ;
Bertone, Elena ;
Frigerio, Luigi ;
Scarfone, Giovanna ;
Perrone, Myriam ;
Bocciolone, Luca ;
Savarese, Antonella ;
Pignata, Sandro ;
Mangili, Giorgia .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[12]   Surveillance After Initial Surgery for Pediatric and Adolescent Girls With Stage I Ovarian Germ Cell Tumors: Report From the Children's Oncology Group [J].
Billmire, Deborah F. ;
Cullen, John W. ;
Rescorla, Frederick J. ;
Davis, Mary ;
Schlatter, Marc G. ;
Olson, Thomas A. ;
Malogolowkin, Marcio H. ;
Pashankar, Farzana ;
Villaluna, Doojduen ;
Krailo, Mark ;
Egler, Rachel A. ;
Rodriguez-Galindo, Carlos ;
Frazier, A. Lindsay .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (05) :465-470
[13]   Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies [J].
Boussios, Stergios ;
Zarkavelis, George ;
Seraj, Esmeralda ;
Zerdes, Ioannis ;
Tatsi, Konstantina ;
Pentheroudakis, George .
ANTICANCER RESEARCH, 2016, 36 (10) :5031-5042
[14]   The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors [J].
Brown, J ;
Shvartsman, HS ;
Deavers, MT ;
Ramondetta, LM ;
Burke, TW ;
Munsell, MF ;
Gershenson, DM .
GYNECOLOGIC ONCOLOGY, 2005, 97 (02) :489-496
[15]  
Brown JR, 1996, HUM REPROD, V11, P197
[16]   Gynecologic Cancer Intergroup (GCIG) Consensus Review for Ovarian Germ Cell Tumors [J].
Brown, Jubilee ;
Friedlander, Michael ;
Backes, Floor J. ;
Harter, Philipp ;
O'Connor, Dennis M. ;
Rouge, Thibault de la Motte ;
Lorusso, Domenica ;
Maenpaa, Johanne ;
Kim, Jae-Weon ;
Tenney, Meghan E. ;
Seckl, Michael J. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) :S48-S54
[17]   Efficacy and Safety of Bevacizumab in Recurrent Sex Cord-Stromal Ovarian Tumors [J].
Brown, Jubilee ;
Brady, William E. ;
Schink, Julian ;
Van Le, Linda ;
Leitao, Mario ;
Yamada, S. Diane ;
de Geest, Koen ;
Gershenson, David M. .
CANCER, 2014, 120 (03) :344-351
[18]   A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study* [J].
Burton, Elizabeth R. ;
Brady, Mark ;
Homesley, Howard D. ;
Rose, Peter G. ;
Nakamura, Toshiaki ;
Kesterson, Joshua P. ;
Rotmensch, Jacob ;
Thigpen, J. Tate ;
Van Le, Linda .
GYNECOLOGIC ONCOLOGY, 2016, 140 (01) :48-52
[19]   Prognostic factors responsible for survival in sex cord stromal tumors of the ovary - A multivariate analysis [J].
Chan, JK ;
Zhang, M ;
Kaleb, V ;
Loizzi, V ;
Benjamin, J ;
Vasilev, S ;
Osann, K ;
DiSaia, PJ .
GYNECOLOGIC ONCOLOGY, 2005, 96 (01) :204-209
[20]   Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women [J].
Chen, Hengxi ;
Xiao, Li ;
Li, Jinke ;
Cui, Lin ;
Huang, Wei .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (03)
123456789